Cargando…

Ipilimumab and immune-mediated adverse events: a case report of anti-CTLA4 induced ileitis

BACKGROUND: Ipilimumab is a fully human monoclonal antibody directed against cytotoxic T-lymphocyte antigen-4 , a key negative regulator of T-cell activation approved by the Food and Drug Administration as of March 2011 for the treatment of metastatic melanoma. As a result of the up-regulation of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Venditti, Olga, De Lisi, Delia, Caricato, Marco, Caputo, Damiano, Capolupo, Gabriella Teresa, Taffon, Chiara, Pagliara, Elisa, Battisi, Sofia, Frezza, Anna Maria, Onetti Muda, Andrea, Tonini, Giuseppe, Santini, Daniele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350587/ https://www.ncbi.nlm.nih.gov/pubmed/25885696 http://dx.doi.org/10.1186/s12885-015-1074-7

Ejemplares similares

Adverse Events Following Administration of Anti-CTLA4 Antibody Ipilimumab
por: Karimi, Amirali, et al.
Publicado: (2021)

Proof-of-concept Raman spectroscopy study aimed to differentiate thyroid follicular patterned lesions
por: Rau, Julietta V., et al.
Publicado: (2017)

Deregulation of dicer and mir-155 expression in liposarcoma
por: Vincenzi, Bruno, et al.
Publicado: (2015)

RAMAN spectroscopy imaging improves the diagnosis of papillary thyroid carcinoma
por: Rau, Julietta V., et al.
Publicado: (2016)

Immune-Mediated Adverse Events Associated with Ipilimumab CTLA-4 Blockade Therapy: The Underlying Mechanisms and Clinical Management
por: Tarhini, Ahmad
Publicado: (2013)

CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations
por: Camacho, Luis H
Publicado: (2015)

Regional Ileitis
por: Jeffrey, James S.
Publicado: (1949)

Regional Ileitis
por: Kaikini, V. M.
Publicado: (1938)

Sentinel lymph node mapping procedure in T1 colorectal cancer: A systematic review of published studies
por: Di Berardino, Stefano, et al.
Publicado: (2019)

Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies
por: He, Mengnan, et al.
Publicado: (2017)

A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma
por: Maki, Robert G., et al.
Publicado: (2013)

CTLA-4 antibody ipilimumab negatively affects CD4(+) T-cell responses in vitro
por: Rosskopf, Sandra, et al.
Publicado: (2019)

Ileitis: A Case
por: Breed, S. P.
Publicado: (1869)

CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
por: Fietz, Simon, et al.
Publicado: (2020)

Hepatic Portal Venous Gas and Anastomotic Leakage
por: Carannante, Filippo, et al.
Publicado: (2020)

Tumor associated macrophages polarization dictates the efficacy of BCG instillation in non-muscle invasive urothelial bladder cancer
por: Suriano, Francesca, et al.
Publicado: (2013)

Crohn's ileitis and salpingo-oophoritis.
por: Allen, D. C., et al.
Publicado: (1995)

Regional Ileitis (Crohn's Disease)
Publicado: (1943)

Capecitabine-induced terminal ileitis
por: Al-Gahmi, Aboelkhair Mohammad, et al.
Publicado: (2012)

Capecitabine-Associated Terminal Ileitis
por: van Hellemond, Irene E.G., et al.
Publicado: (2018)

Management of Asymptomatic Terminal Ileitis
por: Donet, Jean A, et al.
Publicado: (2020)

Understanding the Presentation of Terminal Ileitis
por: Jain, Ashali, et al.
Publicado: (2022)

Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 Levels
por: Leung, Anna M., et al.
Publicado: (2014)

The role of macrophages polarization in predicting prognosis of radically resected gastric cancer patients
por: Pantano, Francesco, et al.
Publicado: (2013)

Terminal ileitis is not always Crohn’s disease
por: Bojic, Daniela, et al.
Publicado: (2011)

Ileitis Secondary to Oral Capecitabine Treatment?
por: Radwan, Rami, et al.
Publicado: (2012)

Radiation Ileitis Leading to Enterovesical Fistula
por: Hokama, Akira, et al.
Publicado: (2022)

O-Ring Protector in Prevention of SSIs in Laparoscopic Colorectal Surgery
por: Capolupo, Gabriella Teresa, et al.
Publicado: (2019)

An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients
por: Colston, Elizabeth, et al.
Publicado: (2018)

Lack of Correlation Between Liver Tests Abnormalities and Trabectedin Efficacy in the Treatment of Soft Tissue Sarcoma: a Retrospective Study
por: Vincenzi, Bruno, et al.
Publicado: (2015)

Ileo-ileal intussusception caused by small bowel leiomyosarcoma: A rare case report
por: Mazzotta, Erica, et al.
Publicado: (2020)

Ipilimumab in the treatment of metastatic melanoma: management of adverse events
por: Della Vittoria Scarpati, Giuseppina, et al.
Publicado: (2014)

Adverse events induced by nivolumab and ipilimumab combination regimens
por: Somekawa, Kohei, et al.
Publicado: (2022)

2081: Phenotypic characterization of the CD4+ T-cell response during anti-CTLA4 therapy with ipilimumab in melanoma patients
por: Sherani, Farha, et al.
Publicado: (2018)

Eosinophilic ascites due to severe eosinophilic ileitis
por: Setia, Namrata, et al.
Publicado: (2010)

Spilled gallstones simulating peritoneal carcinomatosis: A case report and literature review
por: Capolupo, G.T., et al.
Publicado: (2018)

Hepatic portal venous gas after colonoscopy: A case report and review
por: Capolupo, G.T., et al.
Publicado: (2018)

An omental mass. Any idea?
por: Mascianà, G., et al.
Publicado: (2019)

The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
por: Voskens, Caroline J., et al.
Publicado: (2013)

SHIP deficiency causes Crohn's disease-like ileitis
por: Kerr, William G, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_f31906a4280cajfbffp3rjsg1n